Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Pluristem Fast Forwards Placental Cell Therapy Into US-EU Pivotal Trial

Executive Summary

Off-the-shelf placental cell therapy for peripheral artery disease will move from Phase I to registration stage study in US and Europe in early 2017, following “positive feedback” from FDA.

Advertisement

Related Content

Video: Pluristem Says Its Placental Stem Therapy Offers "Off The Shelf" Promise
Cell Therapy Developers Debate Challenges As Big Pharma Drags Its Feet

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register